This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mulder, N., Willemse, P., Schraffordt Koops, H. et al. Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. Br J Cancer 62, 1006–1007 (1990). https://doi.org/10.1038/bjc.1990.427
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.427
This article is cited by
-
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines
Cancer Immunology Immunotherapy (1992)